Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer. - Armstrong A; Seibert T; McKenzie J; Howard L; Ashraf B; Lu J; White K; George D; Shevach J; Park J; Cockrell D; Davis K; et al. (Research square, 2026)